Chokri Ben Lamine: Approach to Intra-Operative Bleeding in G6P Deficiency – Key Causes and Management
Chokri Ben Lamine, Adult Hematology and Stem Cell Transplantation Assistant Consultant at Oncology Center of Excellence at King Faisal Specialist Hospital and Research Center, shared a post on X:
“G6PD Deficiency and Intra-Operative Bleeding
Differential Diagnosis (DDx)
Not always due to G6PD deficiency itself! Think:
•Oxidative drug exposure (e.g., sulfa, quinolones, methylene blue) → acute hemolysis → anemia → bleeding risk
• Sepsis / stress → hemolysis
•Coagulopathy unrelated to G6PD (DIC, liver dysfunction, massive transfusion effect)
•Surgical/technical bleeding cause
•Platelet dysfunction (drugs, uremia)
•Vitamin K deficiency / anticoagulant exposure
Approach
•Stabilize – secure hemodynamics, transfuse PRBC/FFP/platelets as indicated
•Stop oxidative triggers – avoid sulfa, dapsone, quinolones, methylene blue
•Investigate – CBC, retics, LDH, haptoglobin, bilirubin, smear (Heinz bodies, bite cells )
•Correct coagulopathy – INR/PTT, fibrinogen → give FFP, cryo as needed
•Rule out surgical cause – surgical hemostasis review
•Support – hydration, urine alkalinization if hemolysis with hemoglobinuria
•Consult hematology – intra-op support plan, transfusion thresholds
Key Pearl:
Bleeding in G6PD deficiency intra-op is usually secondary to oxidant-induced hemolysis + anemia or unrelated acquired coagulopathy, not a primary platelet/clotting defect.”
More posts featured in Hemostasis Today.
-
Mar 12, 2026, 20:44Honoring Marion Stolte’s Lasting Impact on the Bleeding Disorders Community – WFH
-
Mar 12, 2026, 20:37Paul Riley: Is Thrombin Generation Assay Ready for Prime Time?
-
Mar 12, 2026, 20:28Rob Maloney: Building Visibility for Bleeding Disorders in Rural Georgia
-
Mar 12, 2026, 20:19Akshat Jain: Validating Oral Pain Medication Use as a Global Marker in Sickle Cell Disease
-
Mar 12, 2026, 20:13Michael Makris: Early Clinical Results of AAV8-BDD FVIII Gene Therapy in Hemophilia A
-
Mar 12, 2026, 20:02Wolfgang Miesbach: From Heparin to Vaccines – The Expanding Biology of Anti-PF4 Immunothrombosis
-
Mar 12, 2026, 19:56Christophe Dubois: Celebrating Nicolas Gendron’s HDR Defense and Future in Hemostasis
-
Mar 12, 2026, 17:06Caitlin Raymond: Managing Crigler–Najjar Syndrome Type 1 Crisis Without a Standard TPE Protocol
-
Mar 12, 2026, 17:03Jan Sloves: Insights on Comprehensive Venous Duplex Imaging at VEITH Symposium 2025